Regeneron’s Antibody Therapy A Lifesaver In Seronegative COVID-19 Patients

Another Landmark For RECOVERY Trial

 
• By Andrew McConaghie
  
Regeneron
Regeneron will share the data with regulators and seek an expanded EUA in the US
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip